Irregular heartbeat, paralysis, and cardiac arrest are just some of the side effects caused by one of the leading oral birth control pills on the market — Yaz. It’s not the only birth control method with alarming side effects, though. NuvaRing, a 2-inch insertable birth control ring, became a popular alternative to the pill since its introduction in 2001. But it didn’t come without some serious side effects of its own, including increased risk of blood clots, heart attack, and stroke.

Aside from the increasing norm of prescribing birth control to menstruating girls, the list of dangers associated with the methods may outweigh the benefits. Parents of daughters lost to the effects of Yaz and NuvaRing speak candidly and passionately of the risk factors associated with the method. Today one out of every five girls in America between the ages of 13 and 18 are on birth control — that’s 2.5 million teens in total, according to a study conducted by Reuters.

Today, 63.7 percent of women go off the pill within the first year due to unwanted side effects, according to a video produced by The Guardian. For many young women, the side effects lead to death, leaving parents heartbroken, outraged, and outspoken.

Even after 74 percent of fourth-generation Yaz users developed blood clots, the Food and Drug Administration (FDA) voted to not remove it from the market. The FDA has been watching the Bayer-manufactured pill since 2003 but has done little except accuse the company of running misleading advertisements that minimalized the contraceptive’s risks, according to Drug Watch.

“Thousands of lawsuits and their product is still on the market?” father Joe Malone of deceased victim 23-year-old Brittany Malone, said on camera. “I’m told that I should file a report with the FDA and they said, ‘Unfortunately, we don’t have much funding. We don’t have enough funding to respond to all of these.’ And I said, ‘But my daughter died. She died because of this product.’”

A few years later, the FDA was sent a petition representing more than 100,000 consumers requesting a ban be made for oral contraceptives due to the risk of death. The petition was unsuccessful, and NuvaRing’s sales hit $623 million in 2011, which just kept soaring from there. It’s been prescribed more than 5.5 million times despite the serious side effects associated with its use.

Both Yaz and NuvaRing have hurdled over lawsuit after lawsuit. In 2014, Merck agreed to pay $100 million to settle more than 1,700 NuvaRing lawsuits, allocating approximately $58,000 for each woman or family members surviving one of the 83 deaths. Meanwhile, an estimated 11,000 lawsuits have been filed against Bayer in federal and state courts. So far, the company has only settled 70 cases.